Inhibiting non-hematopoietic cancer with interleukin 6

摘要

Use of IL-6 for treating non-hematopoietic cancers, e.g., gp130-negative cancers. Also disclosed is a method for identifying a cancer patient suitable for the IL-6 treatment.